Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy

ConclusionThis proof-of-concept study thus shows the feasibility of using these fourth-generation FR α-CAR T cells for adoptive T cell therapy in BC.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research